CPRX
Catalyst Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$31.49
+0.00%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+21.4%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jun 5, 2026 | Andrews William T. · officer: Chief Medical Officer | M-Exempt | 3,052 | $0.00 |
| Jun 5, 2026 | Andrews William T. · officer: Chief Medical Officer | F-InKind | 743 | $0.00 |
| Feb 19, 2026 | Russo Gregg · officer: Chief HR Officer | F-InKind | 211 | $0.00 |
| Feb 19, 2026 | Russo Gregg · officer: Chief HR Officer | M-Exempt | 687 | $0.00 |
| Jan 6, 2026 | Daly Richard J · director, officer: President and CEO | F-InKind | 10,577 | $0.00 |
| Jan 6, 2026 | Daly Richard J · director, officer: President and CEO | M-Exempt | 42,105 | $0.00 |
| Jan 6, 2026 | Kalb Michael Wayne · officer: Executive Vice President & CFO | M-Exempt | 7,139 | $0.00 |
| Jan 6, 2026 | Kalb Michael Wayne · officer: Executive Vice President & CFO | F-InKind | 2,080 | $0.00 |
| Dec 30, 2025 | MCENANY PATRICK J · director, other: Chairman of Board of Directors | M-Exempt | 26,334 | $0.00 |
| Dec 30, 2025 | Tierney David S · director | M-Exempt | 1,334 | $0.00 |
| Dec 30, 2025 | Sundaram Preethi · officer: Chief Strategy Officer | F-InKind | 2,369 | $0.00 |
| Dec 30, 2025 | Harper Molly · director | M-Exempt | 1,334 | $0.00 |
| Dec 30, 2025 | Daly Richard J · director, officer: President and CEO | M-Exempt | 1,334 | $0.00 |
| Dec 30, 2025 | Elsbernd Brian · officer: Chief Compliance/Legal Officer | F-InKind | 2,623 | $0.00 |
| Dec 30, 2025 | Elsbernd Brian · officer: Chief Compliance/Legal Officer | M-Exempt | 6,667 | $0.00 |
| Dec 30, 2025 | Del Carmen Jeffrey · officer: Chief Commercial Officer | M-Exempt | 8,667 | $0.00 |
| Dec 30, 2025 | Daly Richard J · director, officer: President and CEO | F-InKind | 524 | $0.00 |
| Dec 30, 2025 | Del Carmen Jeffrey · officer: Chief Commercial Officer | F-InKind | 3,839 | $0.00 |
| Dec 30, 2025 | Sundaram Preethi · officer: Chief Strategy Officer | M-Exempt | 6,667 | $0.00 |
| Dec 30, 2025 | Miller Steve · officer: Chief Op. & Scientific Officer | M-Exempt | 14,000 | $0.00 |
| Dec 30, 2025 | MCENANY PATRICK J · director, other: Chairman of Board of Directors | F-InKind | 6,786 | $0.00 |
| Dec 30, 2025 | DENKHAUS DONALD A · director | M-Exempt | 1,334 | $0.00 |
| Dec 16, 2025 | Harper Molly · director | Sale | 6,746 | $23 |
| Dec 16, 2025 | Harper Molly · director | Sale | 4,473 | $24 |
| Dec 16, 2025 | Harper Molly · director | Sale | 15,527 | $23 |
| Dec 16, 2025 | Harper Molly · director | M-Exempt | 20,000 | $5.78 |
| Dec 10, 2025 | Del Carmen Jeffrey · officer: Chief Commercial Officer | M-Exempt | 8,039 | $0.00 |
| Dec 10, 2025 | DENKHAUS DONALD A · director | M-Exempt | 1,413 | $0.00 |
| Dec 10, 2025 | Elsbernd Brian · officer: Chief Compliance/Legal Officer | F-InKind | 2,780 | $0.00 |
| Dec 10, 2025 | Tierney David S · director | M-Exempt | 1,413 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 157Increased 263Reduced 247Sold out 83
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BlackRock, Inc. | Increased | 19,158,785 | Aug 7, 2026 |
| BLACKROCK, INC. | Increased | 18,774,530 | May 13, 2026 |
| STATE STREET CORP | Increased | 7,627,036 | Aug 7, 2026 |
| STATE STREET CORP | Reduced | 6,863,060 | May 15, 2026 |
| AMERICAN CENTURY COMPANIES INC | Increased | 5,553,921 | Aug 12, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 5,135,345 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 5,122,666 | May 15, 2026 |
| AMERICAN CENTURY COMPANIES INC | Increased | 4,138,416 | May 15, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | Reduced | 3,943,600 | May 15, 2026 |
| DIMENSIONAL FUND ADVISORS LP | Increased | 3,634,171 | Aug 11, 2026 |
| GLAZER CAPITAL, LLC | New Position | 3,602,865 | Aug 17, 2026 |
| DIMENSIONAL FUND ADVISORS LP | Increased | 3,429,615 | May 7, 2026 |
| JPMORGAN CHASE & CO | Increased | 3,169,902 | Aug 12, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 3,150,256 | Aug 12, 2026 |
| BANK OF AMERICA CORP /DE/ | Increased | 3,036,546 | May 18, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jun 5, 2026